Efficiency and safety assessment of donepezil for treating mild and moderate Alzheimer disease

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 13, 2005, Pages 170-172

  Peng, Dan Tao ^a   Xu, Xian Hao ^a   Wang, Lu Ning ^b  

^a Peking Union Hospital   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; PLACEBO;

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; APPETITE DISORDER; ARTICLE; CHOLINERGIC ACTIVITY; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NAUSEA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SINGLE BLIND PROCEDURE; THORAX RADIOGRAPHY;

EID: 27644561070     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rogers SL, Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 1998; 8(1): 67-75
2. Xu XH. Neruoimmunology. Wuhan: Hubei Science and Technology Press 2000: 327-33
3. Perry EK, Perry RH, Blessed G, et al. Necroposy evidence of central cholinergic deficits in senile dementia. Lancet 1977; 1(8004): 189
4. Davis KL, Mohs RC, Marin D, et al. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999; 281(15): 1401-6
5. Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998; 50(1): 136-45
6. Brangman SA. Long-term cholinesterase inhibitor therapy for Alzheimer's disease: implications for long-term care. Am J Alzheimers Dis Other Demen 2003; 18(2): 79-84
7. Black S, Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34(10): 2323-32
8. Feldman H, Gauthier S, Hecker J, et al. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc 2003; 51(6): 737-44
9. Chang Y, Xue YL. Progress of Alzheimer's disease pathogenesis. Zhongguo Linchuang Kangfu 2004; 8(4): 693-5
10. Wang R, Zhang JY, Ji ZJ, et al. Effect of APP 17-mer peptide on the neurotoxicity of beta-amyloid: a study on the pathogenesis of senile dementia. Zhongguo Linchuang Kangfu 2004; 8(13): 2546-7
11. Yang H, Wu CB, Qu QM. Estrogen and Alzheimer's disease. Zhongguo Linchang Kangfu 2004; 8(1): 148-50